Literature DB >> 23330969

Conservative management of abnormally invasive placenta: four case reports.

Angela Ramoni1, Eva-Maria Strobl, Johanna Tiechl, Magdalena Ritter, Christian Marth.   

Abstract

Prenatal diagnosis of placenta increta and percreta is essential to avoid potentially life-threatening hemorrhage by optimizing peripartal management. Invasive placentation presents significant challenges at cesarean section even for highly skilled surgeons. In the four cases of placenta increta/percreta presented here we tried to avoid hysterectomy by leaving the placenta behind and tried to accelerate regression of placental tissue by administering methotrexate. The outcome in each of the four women was different, but no major bleeding occurred in any of the cases. Close follow-up for many weeks is mandatory.
© 2013 The Authors Acta Obstetricia et Gynecologica Scandinavica © 2013 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23330969     DOI: 10.1111/aogs.12079

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Management of placenta percreta in a Jehovah's Witness patient.

Authors:  Adriana J Wong; Matthew Schlumbrecht; Marilyn Huang
Journal:  BMJ Case Rep       Date:  2018-06-11

2.  Application of abdominal aortic balloon occlusion followed by uterine artery embolization for the treatment of pernicious placenta previa complicated with placenta accreta during cesarean section.

Authors:  Yanli Wang; Guohao Huang; Tian Jiang; Xinwei Han
Journal:  J Interv Med       Date:  2019-09-14

3.  Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes.

Authors:  Paula S Lee; Samantha Kempner; Michael Miller; Jennifer Dominguez; Chad Grotegut; Jessie Ehrisman; Rebecca Previs; Laura J Havrilesky; Gloria Broadwater; Sarah C Ellestad; Angeles Alvarez Secord
Journal:  Gynecol Oncol Res Pract       Date:  2017-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.